Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is unchanged from the same period last year. The company reported quarterly sales of $911.000 thousand which missed the analyst consensus estimate of $1.344 million by 32.23 percent. This is a 25.66 percent increase over sales of $725.000 thousand the same period last year.